Treatment with E7766 (i.v.)demonstrated enhanced IFN-β gene induction and tumor inhibition in a dose-dependent manner in mice with BCG-unresponsive non-muscle invasive bladder cancer [66]. Here, IFNB1 is linked to neoplasm.